| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9313101 | Urology | 2005 | 5 Pages |
Abstract
Bicalutamide is cost-effective compared with flutamide when used for androgen blockade as part of CAB for men with advanced prostate cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Scott Ramsey, David Veenstra, Lauren Clarke, Sanjay Gandhi, Mark Hirsch, David Penson,